321 related articles for article (PubMed ID: 27758046)
1. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
2. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
3. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
4. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
[TBL] [Abstract][Full Text] [Related]
5. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
7. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
[TBL] [Abstract][Full Text] [Related]
8. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
9. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
[TBL] [Abstract][Full Text] [Related]
10. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
[TBL] [Abstract][Full Text] [Related]
11. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
12. Erythroferrone as a sensitive biomarker to detect stimulation of erythropoiesis.
Ramirez Cuevas K; Schobinger C; Gottardo E; Voss SC; Kuuranne T; Tissot JD; Favrat B; Townsend N; Leuenberger N
Drug Test Anal; 2020 Feb; 12(2):261-267. PubMed ID: 31655016
[TBL] [Abstract][Full Text] [Related]
13. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
[TBL] [Abstract][Full Text] [Related]
14. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers.
Athanasiadou I; Christian Voss S; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
J Sports Sci; 2020 Aug; 38(16):1924-1932. PubMed ID: 32543279
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
16. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Shimada K; Kanda F; Maeda K
Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
[No Abstract] [Full Text] [Related]
17. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Schumacher YO; Saugy M; Pottgiesser T; Robinson N
Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin as a new biomarker for detecting autologous blood transfusion.
Leuenberger N; Barras L; Nicoli R; Robinson N; Baume N; Lion N; Barelli S; Tissot JD; Saugy M
Am J Hematol; 2016 May; 91(5):467-72. PubMed ID: 26822428
[TBL] [Abstract][Full Text] [Related]
19. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
[TBL] [Abstract][Full Text] [Related]
20. Influence of combined iron supplementation and simulated hypoxia on the haematological module of the athlete biological passport.
Garvican-Lewis LA; Vuong VL; Govus AD; Schumacher YO; Hughes D; Lovell G; Eichner D; Gore CJ
Drug Test Anal; 2018 Apr; 10(4):731-741. PubMed ID: 28929623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
